Search results (427)
« Back to NewsNew research reveals druggable target arising from chromosomal rearrangement in aggressive leukaemia
10 June 2025
RDM researchers have uncovered a potential new therapeutic target in a particularly aggressive and hard-to-treat form of leukaemia.
Congratulations to our new Associate Professors
5 June 2025
RDM is delighted to announce that the title of Associate Professor has been conferred on four of our researchers.
New research will map the impact of sleep and circadian rhythm disruption on cardiometabolic disease
4 June 2025
In the UK more than 4.3 million people live with Type-2 Diabetes, and 2.4 million more are at increased risk of developing the disease. Type-2 Diabetes, obesity, hypertension, and fatty liver disease frequently cluster together in the same individuals. It is becoming clear that sleep and body clock problems have a role to play in this ‘cardiometabolic multimorbidity’, but its exact nature is under-researched.
Diabetes UK Early Career Investigator Award for Dr Thomas Hill
30 April 2025
Congratulations to Dr Thomas Hill who has received a Diabetes UK Early Career Investigator Award at the Diabetes UK Professional Conference.
Daniela Nasteska showcases diabetes research in new Oxford Sparks video
29 April 2025
RDM’s Dr Daniela Nasteska introduces the colourful world of diabetes research via a brand-new video produced by Oxford Sparks.
Technician Champion appointed in RDM
2 April 2025
Facility Manager Michalina Mazurczyk, based in the MRC Weatherall Institute of Molecular Medicine, has been appointed as Technician Champion for the second year.
EAS Young Investigator Fellowship for Michail Mavrogiannis
1 April 2025
Congratulations to Michail Mavrogiannis who has been awarded an EAS Young Investigator Fellowship.
Landmark study finds no benefit of routine use of cerebral embolic protection devices on TAVI stroke risk
31 March 2025
Researchers say the devices cannot be recommended for routine clinical use in the UK.
New study reveals details of key immune mechanism
25 March 2025
An international collaboration, initiated by the Jackson Group at the MRC Weatherall Institute of Molecular Medicine, has uncovered new information that could help in the development of drugs to block conditions such as autoimmunity and inflammation.
Ancient genomic linkage regulates red blood cell development
24 March 2025
A collaboration between the Drakesmith and Higgs Groups at the MRC Weatherall Institute of Molecular Medicine has identified an ancient connection between metabolic and transcriptional control of erythropoiesis.
Catch up on RDM Day 2025
24 March 2025
Over 300 staff and students gathered to connect and celebrate the inspirational science happening across our Department.
Adam Wilkinson wins 2025 ISEH Janet Rowley Award
13 March 2025
Associate Professor Adam Wilkinson has received the 2025 Janet Rowley Award from the International Society for Experimental Haematology for his outstanding contributions in the field of hematopoietic stem cell biology.
Announcing our new Principal Investigators 2025
12 March 2025
Following the RDM’s annual call for researchers to apply for Principal Investigator (PI) status, we are delighted to announce the designation of five new PIs for 2025.
Prestigious Professor Heimburger Award for Dr Jeries Abu-Hanna
4 March 2025
Congratulations to Dr Jeries Abu-Hanna who has been selected as one of the five winning recipients for the Professor Heimburger Award 2025 in the field of inherited haemophilia.
2024 RDM Award for Excellent Supervision Winners
3 March 2025
Congratulations to Professor Leanne Hodson and Dr James Grist who have each received the RDM Award for Excellent Supervision 2024.
New research findings help identify those most at risk of developing hypertrophic cardiomyopathy
27 February 2025
Two new research papers, published in Nature Genetics, jointly led by RDM’s Professor Hugh Watkins, have further advanced our understanding of the genetic basis of hypertrophic cardiomyopathy (HCM).
Clinical trials begin for a first-in-class, inhaled gene therapy for people with cystic fibrosis
25 February 2025
An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their mutation type, is being tested in human trials in the UK and Europe.
Major international career award for Dr Roshan Xavier
10 February 2025
Congratulations to Dr Roshan Xavier who has won a major international career award at the Society for Cardiovascular Magnetic Resonance for his DPhil research into a common form of heart failure called HFpEF.
2024 RDM Graduate Citizenship Award Winners
6 February 2025
Congratulations to the winners of the 2024 RDM Graduate Citizenship Award; Megan Payne and Charlotte Frazer-Morris.
Award to support RDM research in dementia after stroke
3 February 2025
Race Against Dementia, in partnership with Alzheimer’s Research UK have awarded just over £340k to support research into understanding why some people develop dementia after suffering a stroke.